Evaluate the Correlation of NIRS, ABI, Exercise, baPWV and Albuminuria With Peripheral Artery Occlusion Disease (PAD) and Other Atherosclerosis Outcomes
NCT ID: NCT03378024
Last Updated: 2017-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
650 participants
OBSERVATIONAL
2016-12-01
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators plan to collect 140 cases:
1. Healthy subjects with no apparent atherosclerotic risk \[\< 65 y/o, no diabetic mellitus (DM), no hypertension, or no hyperlipidemia, not obese, not current smoker, no smoking history \>10 years\] 4(n=5)
2. Patients at risks (e.g. hypertension, hyperlipidemia) (n=5) but without DM,
3. Type 1 and Type 2 DM patients with normal ABI( \>1.0)and normal Toe-brachial index (TBI) (\> 0.6) without intermittent claudication(by Edinburgh claudication questionnaire), nor PAD diagnosis (n= 10)
4. DM normal ABI\>1.0 and normal TBI (\> 0.6) with suspected symptoms (intermittent claudication, non healing ulcer) (n=10),
5. DM normal or borderline ABI( \>1, 0.91\~0.99) but low TBI (\< 0.6), or with suspected symptoms (intermittent claudication, non healing ulcer) (n=20),
6. DM patients with borderline ABI (0.91-0.99) (n=50) with or without leg symptoms,
7. DM patients abnormal Low ABI (\<0.9) (n=30) with or without leg symptoms,
8. DM patients abnormal high ABI (\> 1.3) (n=10)with or without leg symptoms, Post-exercise ABI with APP, and NIRS examination during APP exercise test will be performed.
The investigators also plan to collect 500 cases of nonpregnant, ≥ 40 years old DM patients, obtained baPWV and the resting ABI by oscillometric device (Omron colin, Japan). The investigators will apply this novel technique to assess the extent of arteriosclerosis and atherosclerosis by oscillometric device in our DM patient without PAD (ABI \>0.9).
Collect baseline characteristics and follow up annual data: Age, sex, body weight, height, BMI, waist circumferences, history of smoking (ex-smoker, current), coexisting hypertension, hyperlipidemia, DM duration, presence of chronic DM complications of neuropathy, retinopathy (by fundus camera), nephropathy (cr, estimate glomerular filtration rate(eGFR), proteinuria, microalbuminuria). The biochemistry data involving atherosclerotic risk including: systolic blood pressure, diastolic pressure, mean pulse pressure, HbA1c, total cholesterol, LDL-Cholesterol(LDL-C), HDL-Cholesterol(HDL-C), triglyceride, creatinine, microalbuminuria,, high sensitive C-Reactive Protein (hs CRP), baseline EKG all will be collected. All the above data will be followed up annually for 3 years to analyze the correlation of progressive change of baPWV, ABI and microalbuminuria with the atherosclerosis event and mortality.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
diabetic mellitus patients
Measure the brachial-ankle pulse wave velocity (baPWV) and the resting ankle-brachial index(ABI) of pre-exercise and post-exercise by the oscillometric (Omron Colin co.).
And follow up for 3 years to identify of the correlation with PAD outcome.
oscillometric (Omron Colin co)
fast measurements of the brachial-ankle pulse wave velocity (baPWV) and the resting ankle-brachial index(ABI) with the oscillometric method (Omron Colin co, Japan)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oscillometric (Omron Colin co)
fast measurements of the brachial-ankle pulse wave velocity (baPWV) and the resting ankle-brachial index(ABI) with the oscillometric method (Omron Colin co, Japan)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* type 2 diabetic patients
Exclusion Criteria
* Critical limb ischemia (gangrene change)
* A permanent pacemaker implant
* Systolic BP ≥ 200 mmHg or diastolic BP ≥100 mmHg
* Symptomatic orthostatic blood pressure drop ≥ 20 mmHg
* Severe critical aortic stenosis
* Acute medical illness, fever, systemic infection
* Uncontrolled atrial or ventricular dysrhythmias
* Uncontrolled sinus tachycardia≥ 120/min
* Peripheral venous insufficiency, thrombosis or thrombophlebitis
* Those who has factors known to influence the PWV
* The brachial-ankle PWV could not be measured on the right and left sides
* Orthopedic condition (ankle or foot) that cannot perform an active pedal plantar flexion (APP) technique (arthritis, hemiparesis, balance impairment etc.)
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ng Soh Ching, MD
Role: PRINCIPAL_INVESTIGATOR
Chang Gung Memorial Hospital, Keelung
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMRPG2F0181
Identifier Type: -
Identifier Source: org_study_id